http://www.tri-conference.com/track6_STM.asp

Comprehensive Coverage: = Current Clinical Perspectives - Reaping the Harvest

= Business Development - Supporting a Scientific Revolution

= Stem Cells for Therapeutic Strategies
- Developing Unique Treatments
- Realizing Regenerative Healing

= Selection, Markers, and Expansion - Answering the Biology of "Stemness"

= Stem Cells as Drug Screening Tools - Revolution in Discovery & Development

Molecular Medicine Tri-Conference Plenary Keynote Presentations: The 2029 Project: The Future of Biomedical R&D
Mr. Jonathan Peck, Vice President, Institute for Alternative Futures

New Approaches to Increasing Productivity in R&D: Data Driven
Development versus Activity Driven Development
Dr. Mahdi Fawzi, Executive Vice President, Preclinical Development,
Wyeth Pharmaceuticals

The Future of Academic Medicine: Improving Healthcare with New
Scientific Discoveries and Bringing Innovations to Patients
Dr. Jocalyn Clark, Associate Editor, British Medical Journal

Conference-At-A-Glance:
Current Clinical Perspectives - Reaping the Harvest

Insiders Report
The Cultural Politics of Stem Cells: It's Not (Just) About the Embryo
Mr. Brian Alexander, Author & Former Biotech Editor, Wired Magazine

Beyond Cord Blood: Umbilical Cord Blood and Matrix Cells Combined
Dr. Curtis L. Cetrulo, Professor, OB/GYN, Maternal Fetal Medicine, Tufts University
School of Medicine

Business Development - Supporting a Scientific Revolution
Managing Culture Change in Biomedical/Pharmaceutical Research
Mr. Eric Morfin, Director, Project Management Office, Chiron

Communication Issues in Stem Cell Research and Business
Ms. Marcia Kean, CEO, Feinstein Kean Healthcare

SCS - A New Age Business Model for a New Age Industry
Dr. Peter Mountford, CEO, Stem Cell Sciences

Lost in Translation? - Addressing Regulatory Concerns While Bridging from
Research to Clinical Applications of Stem Cells
Dr. Darin J. Weber, Senior Consultant, The Biologics Consulting Group, LLC

Stem Cells for Therapeutic Strategies- Developing Unique Treatments
Development of Pluripotent Stem Cell Therapies for Ischemic Injury and
Disease
Dr. Robert Deans, VP, Regenerative Medicine, Athersys, Inc.

Adipose-derived Stem Cells Are an Abundant Population for Repair of
Ischemic Cardiovascular Tissues
Dr. Keith March, Professor and Director, Indiana Center for Vascular Biology and
Medicine,Indiana University

Identification of Putative Hepatic Progenitor Cells in Adult Humans
Dr. Ursula Gehling, Head of the Research Laboratory, Hepatobiliary Surgery and
Visceral Transplantation, University Hospital Hamburg-Eppendorf

Role of Stem Cells in Human Cancer
Dr. Wilfred Stein, Professor, Cancer Therapy Branch, National Cancer Institute/NIH

Stem Cells for Therapeutic Strategies - Realizing Regenerative Healing
Generation of Clinically Relevant ES Cell-Derived Cell Populations
Dr. Stephen L. Minger, Director, Stem Cell Biology Laboratory, Wolfson Centre for
Age-Related Diseases, King's College London

Regeneration in Mammals: Alternatives for Stem Cells
Dr. Tanja Dominko, Chief Scientific Officer, CellThera, Inc.

The Application of a Novel Stem Cell Line for Cell Therapy and Regenerative
Medicine
Dr. Roger De Filippo, Assistant Professor, Urology Department, Children's Hospital
Los Angeles, Saban Research Institute

Ethics and Embryonic Stem Cell Research: Is There A Way Forward?
Dr. William Hurlbut, Professor, Program in Human Biology, Stanford University

Selection, Markers, and Expansion - Answering the Biology of "Stemness"
Tracking the Fate of Stem Cells by Magnetic Resonance Imaging
Dr. Joseph Frank, Chief, Experimental Neuroimaging Section, LDRR/NIH

Basic FGF Drives Large-Scale, Feeder-Independent Culture of Human
Embryonic Stem Cells
Dr. Mark Levenstein, Research Scientist, Biochemistry, WiCell Research Institute

Applications of Microscale Technologies for Stem Cell Biology
Dr. Ali Khademhosseini, Instructor, Harvard University / MIT Division of Health
Sciences and Technology, Harvard-MIT
In vitro Hepatocyte Engineering from Adult Stem Cells: A Potentially
Scalable Resource for Molecular Medicine
Dr. Gary Quinn, Regenerative Medicine, Effector Cell Institute Inc.

Can We Develop Consensus Standards for the Quality of Human ES Cells?
Dr. Jeanne F. Loring, Director, Stem Cell Resource; Co-Director, Exploratory Stem
Cell Center, The Burnham Institute

Technology Workshop
Sponsored by


New Tools and Methods for the Culture and Analysis of Stem Cells
Dr. Sharon Presnell, BD Technologies & Mr. Robert Balderas,Vice President, R&D,
BD Biosciences

Stem Cells as Drug Screening Tools - Revolution in Discovery &
Development
Stem Cells- Expanding the Use to Find Novel Drugs
Ms. Jennie Mather, President and Founder, Raven Biotechnologies, Inc.

The Potential of Stem Cells in Pharmaceutical Drug Discovery
Dr. Aaron T.T. Chuang, Stem Cell Project Leader, Neurology & Gastrointestinal
Centre of Excellence for Drug Discovery, GlaxoSmithKline

Use of Human Embryonic Stem Cells in Drug Discovery
Dr. Petter Bjorquist, R&D, Cellartis AB

A Novel 3-D Embryonic Stem Cell GFP-Based Fluorescence Assay for
High-Throughput Drug Screening and Discovery
Dr. Shang-Tian Yang, Professor, Chemical & Biomolecular Engineering, The
Ohio State University

Efficacy and Safety Assessment of Targets and Compounds in Stem
Cell Models
Dr. John Hambor, Associate Research Fellow, Genetically Modified Models
Center of Emphasis,Pfizer Global Research and Development